Age-Stratified Risk of Carboplatin-Induced Nausea and Vomiting in Lung Cancer Patients
Oncology · 10.03.2025 · 104 (2) · 125-136
DOI: 10.1159/000544875 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, online erschienen am 10.03.2025. Verfasst von Koki Hashimoto und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Japan. Hauptthemen laut MEDLINE: Carboplatin, Lung Neoplasms, Vomiting, Nausea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
Age has been reported as a risk factor for chemotherapy-induced nausea and vomiting. However, few reports have described risk factors for nausea and vomiting with carboplatin (CBDCA). This study investigated whether the incidence of CBDCA-induced nausea and vomiting differs with age, using 70 years as the cutoff.
Methods
Patients who underwent CBDCA for lung cancer at the Cancer Institute Hospital of Japanese Foundation for Cancer Research between November 2020 and October 2023 were included in this retrospective study. The age cutoff was set at 70 years, with the complete response (CR; no vomiting/retching and no rescue medication) rate during the observation period as the endpoint.
Results
Of the 198 patients included in the analysis, 114 (57.6%) were ≥70 years old. The CR rate was 36.9% for patients
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Japan.
- Department of Pharmacy, Cancer Institute Hospital for Japanese Foundation for Cancer Research, Koto-ku, Japan.
- Department of Pharmacy, Cancer Institute Hospital for Japanese Foundation for Cancer Research, Koto-ku, Japan, takashi.yokokawa@jfcr.or.jp.
- Department of Thoracic Medical Oncology, Cancer Institute Hospital for Japanese Foundation for Cancer Research, Koto-ku, Japan.
- School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Japan.
- Department of Clinical Assessment, Tokyo University of Pharmacy and Life Sciences, Hachioji, Japan.
Zitieren
APA
Hashimoto, K., Yokokawa, T., Nonomiya, Y., Shibata, N., Soejima, A., Kobayashi, K., Mae, Y., Hasegawa, A., Aoyama, T., Tateai, Y., Ban, S., Nigata, K., Abe, R., Kawakami, K., Shimizu, H., Ariyasu, R., Yanagitani, N., Hasegawa, K., Kawaguchi, T., …, & Suzuki, K. (2025). Age-Stratified Risk of Carboplatin-Induced Nausea and Vomiting in Lung Cancer Patients. Oncology, 104(2), 125-136. https://doi.org/10.1159/000544875
Vancouver
Hashimoto K, Yokokawa T, Nonomiya Y, Shibata N, Soejima A, Kobayashi K, et al. Age-Stratified Risk of Carboplatin-Induced Nausea and Vomiting in Lung Cancer Patients. Oncology. 2025;104(2):125-136. doi:10.1159/000544875
BibTeX
@article{Hashimoto2025,
author = {Hashimoto, Koki and Yokokawa, Takashi and Nonomiya, Yuma and Shibata, Naoki and Soejima, Azusa and Kobayashi, Kazuo and Mae, Yutaro and Hasegawa, Akiko and Aoyama, Takeshi and Tateai, Yoshikazu and Ban, Shuhei and Nigata, Kotono and Abe, Ryusei and Kawakami, Kazuyoshi and Shimizu, Hisanori and Ariyasu, Ryo and Yanagitani, Noriko and Hasegawa, Kaname and Kawaguchi, Takashi and Yamaguchi, Masakazu and Suzuki, Kenichi},
title = {Age-Stratified Risk of Carboplatin-Induced Nausea and Vomiting in Lung Cancer Patients},
journal = {Oncology},
year = {2025},
volume = {104},
number = {2},
pages = {125--136},
doi = {10.1159/000544875}
}
EUVIMED